Effectiveness of interventions for secondary raynaud's phenomenon: A systematic review

Archives of Physical Medicine and Rehabilitation

Volumn 92, Issue 7, 2011, Pages 1166-1180

  Huisstede, Bionka M ^a   Hoogvliet, Peter ^a   Paulis, Winifred D ^a   Van Middelkoop, Marienke ^a   Hausman, Michael ^b   Coert, J Henk ^a   Koes, Bart W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Drug therapy; General surgery; Hand; Infusions; intra arterial; Peripheral vascular diseases; Rehabilitation

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; BETA CAROTENE; BOSENTAN; CISAPROST; CYCLOFENIL; ENDOTHELIN RECEPTOR ANTAGONIST; GAMMA INTERFERON; ILOPROST; KETANSERIN; LOSARTAN; METHIONINE; NIFEDIPINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PRAZOSIN; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E1; QUINAPRIL; RESERPINE; SELENIUM; STANOZOLOL; TADALIL; UNCLASSIFIED DRUG;

ACUPUNCTURE; CONSERVATIVE TREATMENT; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; HUMAN; LOW LEVEL LASER THERAPY; META ANALYSIS (TOPIC); PERCUTANEOUS RADIOFREQUENCY THORACIC SYMPTHECTOMY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAYNAUD PHENOMENON; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; CALCIUM CHANNEL BLOCKERS; HUMANS; ILOPROST; RADIO WAVES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RAYNAUD DISEASE; VASODILATOR AGENTS;

EID: 79959736094     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2011.01.022     Document Type: Review

References (64)

1. J.C. Bowling, and P.M. Dowd Raynaud's disease Lancet 361 2003 2078 2080 (Pubitemid 36695055)
2. P.H. Carpentier, B. Satger, D. Poensin, and H.R. Maricq Incidence and natural history of Raynaud phenomenon: a long-term follow-up (14 years) of a random sample from the general population J Vasc Surg 44 2006 1023 1028 (Pubitemid 46107246)
3. J.E. Pope The diagnosis and treatment of Raynaud's phenomenon: a practical approach Drugs 67 2007 517 525 (Pubitemid 46440310)
4. T. Grader-Beck, and F.M. Wigley Raynaud's phenomenon in mixed connective tissue disease Rheum Dis Clin North Am 31 2005 465 481 vi (Pubitemid 41111549)
5. J. Wijngaarden, L. Smith, and J. Bennett Cecil textbook of medicine 19th ed. 1992 W.B. Saunders Co Philadelphia
6. V.S. Rajkumar, C. Sundberg, D.J. Abraham, K. Rubin, and C.M. Black Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis Arthritis Rheum 42 1999 930 941 (Pubitemid 29215003)
7. A. Herrick Diagnosis and management of scleroderma peripheral vascular disease Rheum Dis Clin North Am 34 2008 89 114 vii (Pubitemid 351329459)
8. B. Balogh, W. Mayer, M. Vesely, S. Mayer, H. Partsch, and H. Piza-Katzer Adventitial stripping of the radial and ulnar arteries in Raynaud's disease J Hand Surg Am 27 2002 1073 1080 (Pubitemid 35439779)
9. M. van Middelkoop, B.M. Huisstede, S. Glerum, and B.W. Koes Effectiveness of interventions of specific complaints of the arm, neck, or shoulder (CANS): musculoskeletal disorders of the hand Clin J Pain 25 2009 537 552
10. B.M. Huisstede, H.S. Miedema, A.P. Verhagen, B.W. Koes, and J.A. Verhaar Multidisciplinary consensus on the terminology and classification of complaints of the arm, neck and/or shoulder Occup Environ Med 64 2007 313 319 (Pubitemid 46717708)
11. A.D. Furlan, V. Pennick, C. Bombardier, M. van Tulder Editorial Board, Cochrane Back Review Group 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group Spine 34 2009 1929 1941 (Phila Pa 1976)
12. M. van Tulder, A. Furlan, C. Bombardier, L. Bouter Editorial Board of the Cochrane Collaboration Back Review Group Updated method guidelines for systematic reviews in the cochrane collaboration back review group Spine (Phila Pa 1976) 28 2003 1290 1299 (Pubitemid 36734620)
13. S. Harding, P. Tingey, and J. Pope Prazosin for Raynaud's phenomenon in progressive systemic sclerosis Cochrane Database Syst Rev 2 2000 CD000956
14. J. Pope, D. Fenlon, and A. Thompson Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis Cochrane Database Syst Rev 2 2000 CD000953
15. A.E. Thompson, B. Shea, V. Welch, D. Fenlon, and J.E. Pope Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis Arthritis Rheum 44 2001 1841 1847 (Pubitemid 32758232)
16. P. Tingey, S. Harding, and J. Pope Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis Cochrane Database Syst Rev 2 2000 CD000955
17. J. Pope, D. Fenlon, and A. Thompson Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis Cochrane Database Syst Rev 2 2000 CD000954
18. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
19. I.J. Russell, and J.A. Lessard Prazosin treatment of Raynaud's phenomenon: a double blind single crossover study J Rheumatol 12 1985 94 98 (Pubitemid 15131435)
20. R.S. Surwit, R.S. Gilgor, L.M. Allen, and M. Duvic A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma Arch Dermatol 120 1984 329 331 (Pubitemid 14195223)
21. C.S. Lau, J.J. Belch, and R. Madhok A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis Clin Exp Rheumatol 11 1993 35 40 (Pubitemid 23050850)
22. J.J. Belch, H.A. Capell, and E.D. Cooke Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study Ann Rheum Dis 54 1995 197 200
23. M.V. Kyle, G. Belcher, and B.L. Hazleman Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon J Rheumatol 19 1992 1403 1406
24. N.J. McHugh, M. Csuka, and H. Watson Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis Ann Rheum Dis 47 1988 43 47 (Pubitemid 18054520)
25. F.M. Wigley, J.R. Seibold, and R.A. Wise Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis J Rheumatol 19 1992 1407 1414
26. F.M. Wigley, R.A. Wise, and J.R. Seibold Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis A multicenter, placebo-controlled, double-blind study Ann Intern Med 120 1994 199 206
27. D.A. Yardumian, D.A. Isenberg, and M. Rustin Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue Br J Rheumatol 27 1988 220 226
28. F.M. Wigley, J.H. Korn, and M.E. Csuka Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study Arthritis Rheum 41 1998 670 677 (Pubitemid 28214985)
29. C.M. Black, L. Halkier-Sørensen, and J.J. Belch Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study Br J Rheumatol 37 1998 952 960
30. G. Milio, E. Corrado, and C. Genova Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol Rheumatology (Oxford) 45 2006 999 1004 (Pubitemid 44283056)
31. A. Kawald, G.R. Burmester, D. Huscher, C. Sunderktter, and G. Riemekasten Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study J Rheumatol 35 2008 1830 1837
32. H.I. Torley, R. Madhok, and H.A. Capell A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases Ann Rheum Dis 50 1991 800 804
33. B. Marasini, M. Massarotti, and B. Bottasso Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon Scand J Rheumatol 33 2004 253 256 (Pubitemid 39180170)
34. J.S. Mohrland, J.M. Porter, E.A. Smith, J. Belch, and M.H. Simms A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome Ann Rheum Dis 44 1985 754 760 (Pubitemid 16236039)
35. R. Scorza, M. Caronni, and B. Mascagni Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon A randomized, controlled study Clin Exp Rheumatol 19 2001 503 508 (Pubitemid 32894599)
36. S. Bartolone, A. Trifiletti, and G. De Nuzzo Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon Minerva Cardioangiol 47 1999 137 143 (Pubitemid 29372599)
37. W.H. Ettinger, R.A. Wise, D. Schaffhauser, and F.M. Wigley Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon Am J Med 77 1984 451 456 (Pubitemid 14073689)
38. A. Kahan, B. Amor, and C.J. Menkes Nicardipine in the treatment of Raynaud's phenomenon Arthritis Rheum 30 1987 598
39. A. Kahan, J.M. Foult, S. Weber, B. Amor, C.J. Menkes, and M. Degeorges Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon Eur Heart J 6 1985 702 705 (Pubitemid 15236446)
40. A. Kahan, S. Weber, and B. Amor Calcium entry blocking agents in digital vasospasm (Raynaud's phenomenon) Eur Heart J 4 Suppl C 1983 123 129 (Pubitemid 13072466)
41. M. Rademaker, E.D. Cooke, and N.E. Almond Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study BMJ 298 1989 561 564 (Pubitemid 19072096)
42. R.J. Rodeheffer, J.A. Rommer, F. Wigley, and C.R. Smith Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon N Engl J Med 308 1983 880 883 (Pubitemid 13116543)
43. R.H. Meyrick Thomas, M. Rademaker, and S.M. Grimes Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis Br J Dermatol 117 1987 237 241 (Pubitemid 17128477)
44. M. Dziadzio, C.P. Denton, and R. Smith Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial Arthritis Rheum 42 1999 2646 2655 (Pubitemid 30327186)
45. B. Blom-Blow, K. Oberg, and F.A. Wollheim Cyclofenil versus placebo in progressive systemic sclerosis A one-year double-blind crossover study of 27 patients Acta Med Scand 210 1981 419 428 (Pubitemid 12212674)
46. J. Cadranel, O. Bletry, and L. Guillevin [Treatment of systemic scleroderma with ketanserin. Randomized, double-blind 6-months study of 27 cases] [French] Ann Med Interne (Paris) 137 1986 260 263
47. J. Dormandy Clinical use of calcium antagonists in peripheral circulatory disease Ann N Y Acad Sci 522 1988 611 620
48. W. Kirch, H.R. Linder, H.J. Hutt, E.E. Ohnhaus, and F. Mahler Ketanserin versus nifedipine in secondary Raynaud's phenomenon Vasa 16 1987 77 80 (Pubitemid 17014714)
49. J. Lukac, J. Rovensky, H. Tauchmannova, and D. Zitnan Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial Drugs Exp Clin Res 11 1985 659 663 (Pubitemid 16247863)
50. J.P. Ortonne, C. Torzuoli, P. Dujardin, and B. Fraitag Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial Br J Dermatol 120 1989 261 266 (Pubitemid 19055429)
51. H.J. van de Wal, P.F. Wijn, H.J. van Lier, and S.H. Skotnicki The effectiveness of ketanserin in patients with primary Raynaud's phenomenon A randomized, double blind, placebo controlled study Int Angiol 6 1987 313 322 (Pubitemid 18038748)
52. O.K. Roald, and E. Seem Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders Br Med J (Clin Res Ed) 289 1984 577 579 (Pubitemid 14009866)
53. M. Hahn, A. Steins, M. Mhrle, A. Blum, and M. Jnger Is there a vasospasmolytic effect of acupuncture in patients with secondary Raynaud phenomenon? J Dtsch Dermatol Ges 2 2004 758 762 (Pubitemid 39214819)
54. A.L. Herrick, S. Hollis, and D. Schofield A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis Clin Exp Rheumatol 18 2000 349 356 (Pubitemid 30409104)
55. M.I. Jayson, C.D. Holland, A. Keegan, K. Illingworth, and L. Taylor A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis Ann Rheum Dis 50 1991 41 47
56. A.E. Gliddon, C.J. Doré, and C.M. Black Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril Arthritis Rheum 56 2007 3837 3846 (Pubitemid 350100716)
57. A. Abou-Raya, S. Abou-Raya, and M. Helmii Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers J Rheumatol 35 2008 1801 1808
58. E. Schiopu, V.M. Hsu, and A.J. Impens Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis J Rheumatol 36 10 2009 2264 2268
59. V.A. Nguyen, K. Eisendle, I. Gruber, B. Hugl, D. Reider, and N. Reider Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study Rheumatology (Oxford) 49 2010 583 587
60. R.C. Siegel, and J.F. Fries Intra-arterially administered reserpine and saline in scleroderma Arch Intern Med 134 1974 515 518
61. T. Gabrhelik, P. Michalek, M. Adamus, and E. Berta Percutaneous upper thoracic radiofrequency sympathectomy in Raynaud phenomenon: a comparison of T2/T3 procedure versus T2 lesion with phenol application Reg Anesth Pain Med 34 2009 425 429
62. A.M. Yee, R.N. Hotchkiss, and S.A. Paget Adventitial stripping: a digit saving procedure in refractory Raynaud's phenomenon J Rheumatol 25 1998 269 276 (Pubitemid 28088254)
63. T.E. McCall, D.P. Petersen, and L.B. Wong The use of digital artery sympathectomy as a salvage procedure for severe ischemia of Raynaud's disease phenomenon J Hand Surg Am 24 1999 173 177 (Pubitemid 29102438)
64. R. Bakst, J.F. Merola, A.G. Franks Jr, and M. Sanchez Raynaud's phenomenon: pathogenesis and management J Am Acad Dermatol 59 2008 633 653